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mAbstract
Anesthesia-induced altered arousal depends on drugs having their effect in specific
brain regions. These effects are also reflected in autonomic nervous system (ANS)
outflow dynamics. To this extent, instantaneous monitoring of ANS outflow, based
on neurophysiological and computational modeling, may provide a more accurate
assessment of the action of anesthetic agents on the cardiovascular system. This will
aid anesthesia care providers in maintaining homeostatic equilibrium and help to
minimize drug administration while maintaining antinociceptive effects. In previous
studies, we established a point process paradigm for analyzing heartbeat dynamics
and have successfully applied these methods to a wide range of cardiovascular data
and protocols. We recently devised a novel instantaneous nonlinear assessment of
ANS outflow, also suitable and effective for real-time monitoring of the fast
hemodynamic and autonomic effects during induction and emergence from anesthesia.
Our goal is to demonstrate that our framework is suitable for instantaneous monitoring
of the ANS response during administration of a broad range of anesthetic drugs.
Specifically, we compare the hemodynamic and autonomic effects in study participants
undergoing propofol (PROP) and dexmedetomidine (DMED) administration. Our methods
provide an instantaneous characterization of autonomic state at different stages of
sedation and anesthesia by tracking autonomic dynamics at very high time-resolution.
Our results suggest that refined methods for analyzing linear and nonlinear heartbeat
dynamics during administration of specific anesthetic drugs are able to overcome
nonstationary limitations as well as reducing inter-subject variability, thus providing a
potential real-time monitoring approach for patients receiving anesthesia.
Keywords: Autonomic nervous system; Electrocardiogram; Electroencephalogram;
Heart rate variability; Respiratory sinus arrhythmia; Anesthesia; Sedation; Propofol;
Dexmedetomidine; Instantaneous point process monitoringBackground
Despite recent technological advances in anesthetic delivery and monitoring systems
and the growing body of information on molecular mechanisms of anesthetic actions,
most anesthesia care providers monitor drug-induced altered states of arousal with
basic clinical signs (e.g., heart rate, blood pressure). Due to the high prevalence of
anesthesia-related morbidity, more precise monitoring tools are required. In particu-
lar, the administration of anesthetic agents can result in hypotension, hypoxia, and
cardiac dysrhythmias. Post-operative recall of intraoperative events, including sleep2014 Valenza et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly credited.
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stress disorder [1], is also an important source of anesthesia-related morbidity. It is es-
timated that the incidence of awareness under anesthesia is experienced by 20,000 to
40,000 individuals a year in the United States [2]. On the other hand, small surgical op-
erations, as well as most nonsurgical procedures, do not require loss of consciousness
and may be performed without discomfort using reduced doses of anesthetic agents
than are currently used.
It is known that anesthesia-induced altered states of arousal depend on drugs
having their effect in specific brain regions. For instance, propofol (PROP) is a
GABA-A agonist that primarily targets pyramidal neurons in the lower output
layers of the cortex. It elicits reductions in cortical and subcortical responses to
auditory and noxious stimuli. In particular, progressive failure to perceive or re-
spond to auditory or noxious stimuli is associated with a reduction in functional
connectivity between the putamen and other brain regions [3]. Varying the concen-
tration of propofol differentially modulates brain activation [4,5], suggesting that
the effects on the brain are also likely reflected in autonomic nervous system
(ANS) outflow dynamics. Dexmedetomidine (DMED) is an α2 adrenergic agonist
that binds to the receptors in the locus ceruleus with the downstream effect lead-
ing to activation of the ventrolateral preoptic nucleus (VLPO). The active VLPO fa-
cilitates GABA-A and galanin-mediated inhibition of the midbrain, hypothalamic,
and pontine arousal nuclei, promoting altered arousal [6]. It is well established that
changes in neurophysiological recordings such as the electroencephalogram (EEG)
can provide a reliable, empirical characterization of anesthesia-induced loss of con-
sciousness [7,8]. Systematic EEG changes have long been known to occur at differ-
ent levels of intravenous and inhaled anesthetics, including increases in frontal
EEG power [9-15], shifting of the power spectrum towards lower frequencies [16],
changes in coherence [11,17], and in deep anesthesia, burst-suppression and iso-
electricity [18]. These developed metrics could be used in conjunction with ANS
measures for a novel multimodal assessment of ANS reactions to pain during
sedation.
The ANS is known to regulate physiological homeostasis and the organism's response
to environmental and psychological stressors. Innervation of the heart from the ANS
sympathetic branch causes increases in heart rate and vascular constriction. Conversely,
the vagus nerve, the main parasympathetic innervation of the heart, causes a decrease
in heart rate. Anesthetic agents target important brain areas involved in the central
autonomic network, particularly the brainstem centers processing and integrating infor-
mation to generate ANS outflow to multiple organs [6]. As a consequence, virtually
every drug used for sedation has an effect on the ANS, a critical factor to take into ac-
count when assessing nociceptive levels. The effect of anesthetic agent on the ANS var-
ies due to the different neural mechanisms of anesthetic action [6]. For instance,
propofol attenuates autonomic tone and baroreflex responses to hypotension resulting
in a decrease in blood pressure that is largely due to vasodilatation [19-22]. On the
other hand, dexmedetomidine reduces systemic sympathetic tone without altering
baroreflex sensitivity [22-31].
Heart rate variability (HRV) is conventionally defined as the variation in instantan-
eous heart rate around its mean [32]. It is considered to be an important quantitative
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lows for the estimation of the balance between the sympathetic and the parasympathetic
nervous systems. The specific type of general anesthetic agent used has been shown to have
a differential effect on the change of HRV when measured after induction of general
anesthesia [33]. A recent review article by Mazzeo and colleagues [34] summarizes some of
the most relevant findings and limits of HRV as a diagnostic and prognostic tool in
anesthesia and concludes that ‘investigation of HRV as a method of monitoring the depth of
anesthesia, assessing the response to painful stimuli, did not yield uniform results and needs
more extensive investigations.’ Several other important studies have considered HRV to
quantify anesthesia [35-51], demonstrating the usefulness of HRV measures. In particular,
time-varying identification methods have provided successful characterization of PROP and
DMED effects on the ANS [19,20,24,28,44,51]. Several other studies have considered ANS
measures in an attempt to monitor pain during anesthesia [52-63]. However, ANS measures
have yet not been able to provide strong predictive power due to high inter-individual vari-
ability and large random variations within subjects. Due to differences in study populations
and settings, and important limitations in accounting for confounders, such as assisted ven-
tilation, compensative drug administration, or surgical stimulation, a comprehensive com-
parative assessment of the proposed parameters is indeed quite problematic.
The presented work is aimed at combining novel instantaneous measures of autonomic
activity to provide instantaneous monitoring of the ANS response with sedation. In particu-
lar, we have devised a novel assessment of ANS outflow based on instantaneous measures
of autonomic tone able to track fast hemodynamic and autonomic effects during induction
and emergence from altered arousal. In previous studies, we established a paradigm for
using point process methods for analyzing heartbeat dynamics [64,65]. We have also
assessed sympathovagal indices of heart rate variability, as well as baroreflex and respiratory
sinus arrhythmia [66-70], and we have successfully applied these methods to protocols in-
cluding induction and emergence from anesthesia [71-75]. We have further identified spe-
cific measures of complexity and nonlinearity associated with loss of consciousness during
anesthesia [75]. Most importantly, these methods can track autonomic dynamics in real
time. In this study, we present exemplary analyses from a multimodal (EEG, ECG, respir-
ation) characterization in study participants undergoing PROP and DMED administration.
Furthermore, in order to validate the proposed algorithms' ability to track pharmacological
interventions in the operating room (OR) or the intensive care unit (ICU), we focus on how
specific features of our framework are able to characterize instantaneous signatures of the
hemodynamic and autonomic effects of the anesthetics before and during loss of
consciousness.
Methods
Experimental protocol
We have considered experimental datasets from healthy volunteer subjects participating
in two studies approved by the Massachusetts General Hospital (MGH) Institutional
Review Board.
Study 1 Propofol was intravenously infused in six healthy subjects using a computer-
controlled delivery system running STANPUMP connected to a Harvard 22
syringe pump (Harvard Apparatus, Holliston, MA, USA). Five effect-site
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were each maintained for 15 min, respectively, and then step-wise decreased
by 5 mcg/ml per epoch during E6, E7, and E8 before full emergence from
anesthesia. Along the experiment, subjects listened to pre-recorded auditory
stimuli and were instructed to press a button to differentiate between sounds.
We used the loss of button responses as a marker of loss of consciousness
(LOC). EEG, capnography, pulse oximetry, ECG, and arterial BP were recorded
and monitored continuously at 500 Hz throughout the study. Study participants
were also fitted with a respiration belt and a piezo-electric pulse transducer for
monitoring. Bag-mask ventilation with 30% oxygen was administered as needed
in the event of propofol-induced apnea. Because propofol is a potent peripheral
vasodilator, phenylephrine was administered intravenously to maintain mean
arterial BP within 20% of the baseline when needed. This first study includes
results from baseline and increasing propofol concentration levels of two male
and four female subjects between 20 and 32 years old.
Study 2 Dexmedetomidine was intravenously infused in six healthy subjects using a
Medfusion® 3500 syringe infusion pump (Smiths Medical, Dublin, OH, USA).
EEG, capnography, pulse oximetry, and ECG were recorded and monitored
continuously during the study protocol. EEG was sampled at 1,000 Hz, ECG
at 240 Hz. In specific instances, respiration belts were used to record lung
volume changes at 240 Hz. The dexmedetomidine infusion started with a
loading dose of 1 mcg/kg over 10 min followed by an intravenous infusion of
dexmedetomidine to be maintained at a maximum of 0.7 mcg/kg/h. This
second study includes results from the first 28 min of administration of three
male and three female subjects between 21 and 29 years old.Preprocessing analysis
R wave peaks are detected from the ECG signal using an automatic algorithm. The R
wave markers are tested to eliminate artifacts and correct eventual undetected beats or
beats erroneously detected by the automatic peak detection procedure. Ectopic beat
classification is also carried out with our specifically tailored routines [76]. Respiration,
when recorded, is low-pass filtered at 10 Hz.Point process assessment of HRV
The R wave events are a sequence of discrete occurrences in continuous time and
hence, they can be analyzed meaningfully and continuously monitored using a prob-
abilistic model of a dynamical system observed through a point process. In this model,
the observation equation summarizes the stochastic properties of the observed heart
beat point process while the essential features of the parasympathetic and sympathetic
activity are concisely summarized in a history-dependent, autoregressive (AR), time-
varying structure [64,65], allowing for definition of the instantaneous RR and HR mean
and variance, the instantaneous very low frequencies (VLF: 0 to 0.04 Hz), low frequen-
cies (LF: 0.04 to 0.15 Hz), high frequencies (HF: 0.15 to 0.4 Hz) indices in absolute
(ppVLFa, ppLFa, ppHFa) and normalized (ppLFu, ppHFu) spectral power, and the ratio
between LF and HF (ppLF/HF). Vagal activity is the major contributor to the HF
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quantitative marker of sympathetic modulation [77,78], while other studies have found
that LF reflects both sympathetic and vagal activity [79,80]. The LF/HF ratio is consid-
ered to reflect the sympathovagal balance. A thorough review of standard measures is
presented in [32] and [81].
There are several advantages of using a point process framework to assess HRV: (a)
the model overcomes stationarity requirements for standard HRV analysis; (b) previous
methods compute similar estimates either on a beat-to-beat basis or in continuous time
by preprocessing and filtering of the original R-R interval series not justified by a
physiological model of heart beat generation; (c) point process models include
goodness-of-fit analyses supporting accurate description of the heartbeat stochastic
structure; (d) point process instantaneous HRV indices can be computed simultan-
eously from a single statistical framework, they are computed in continuous time, and
they can be extracted at any time resolution to track very fast dynamics; (e) our previ-
ous studies have shown that summaries comparable to standard HRV analysis (e.g.,
SDNN and LF/HF) can be obtained by averaging the instantaneous point process indi-
ces (static measures), which therefore encompass information from standard analysis;
and (f ) only instantaneous dynamics have been proved effective in characterizing
central autonomic activity [82]. These results suggest that static and dynamic measures
derived from point process models are good candidates for a more accurate, compre-
hensive description of ANS outflow dynamics [64,65].Nonlinear assessment
The point process framework also allows for inclusion of nonlinear structures and for
definition of novel indices of nonlinear HRV dynamics, such as the bispectrum [67]
and the instantaneous dominant Lyapunov exponent (IDLE) [75]. Results suggest that
such quantification provides important information, which is independent from the
standard autonomic assessment and is significantly correlated with loss of conscious-
ness. In addition, we have demonstrated [67] that nonlinear indices such as detrended
fluctuation analysis (DFA) and approximate entropy (ApEn) can be more accurately es-
timated by applying those methods to the instantaneous point process series, thus
avoiding the need for long (e.g., 24 h) recordings.RSA assessment
We use an extension of the statistical point process model that we recently developed
[68] to assess instantaneous estimates of respiratory sinus arrhythmia (RSA) from both
ECG and respiration. Where respiratory information is available, we compute two RSA
measures: the RSA gain at maximum coherence and RSA gain at maximum frequency.
The instantaneous RSA assessments provide information that complements the stand-
ard HRV measures, particularly in the high frequency (HF) range, as well as indices
such as the analgesia nociception index (ANI) and the surgical stress index (SSI)
[53,56,57]. Importantly, only our new measures of RSA make it possible to reliably
evaluate RSA in waning breathing conditions or whenever subjects show slow or un-
usual respiratory patterns [68].
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As described in detail in [15], we computed spectrograms using the multitaper method,
implemented in the Chronux toolbox (http://chronux.org). The spectral analysis pa-
rameters were as follows: window length T = 4 s with 3-s overlap, time-bandwidth
product TW = 3, number of tapers K = 5. Although not shown, eigenvector decompos-
ition analysis of the cross-spectral matrix was performed to identify the principal
modes of oscillation. Further modal projection analysis characterized how power within
these principal modes changed as a function of time. The relationship between low-
frequency phase (0.1 to 1 Hz) and alpha/beta (8 to 14 Hz) amplitude was extracted
from the phase-amplitude histogram. These established EEG signatures help to
characterize unconsciousness, track the transitions into and out of unconsciousness,
and provide a means to monitor and predict the hypnotic state of patients under sed-
ation and general anesthesia.Results
Tracking levels of consciousness
The precise dynamics and relative timing of EEG changes during the transition between
consciousness and unconsciousness have been recently described in previous works by
Cimenser et al. and Purdon et al. [13-15]. These experiments found that responses to
auditory stimuli show continuous changes in probability of response. Responses to sali-
ent stimuli (the sound of one's name) are lost later than responses to less salient stimuli
(clicking noises). These features persist and strengthen with increasing concentrations of
propofol and lead to burst suppression at sufficiently high doses. During emergence
from anesthesia, this sequence reverses. Two patterns of phase-amplitude modulation
were also discovered. The ‘peak-max pattern’ occurs in the unconscious state and is
similar in character to slow oscillations observed during slow wave sleep. The ‘trough-
max pattern’ is observed during the transitions to and from unconsciousness with pro-
pofol, whereas weaker and intermittent transitions into and out of unconsciousness are
reported for DMED (see two exemplary spectrograms in Figure 1).Tracking ANS outflow dynamics
Figure 2 shows tracking results from two recordings performed under the two consid-
ered studies, demonstrating how analysis of ANS outflow dynamics is able to provide
critical information about autonomic effects by the two anesthetic agents. It is import-
ant to note that, as the two protocols have very different administration procedures,
the tracking results are proposed together for methodological demonstration purposes
and are not aimed at yielding specific comparative inferences between the two drugs.
In particular, PROP increases cardiovascular instability due to its hypotensive vasodi-
latatory effects, visible shortly after administration in mean RR, mean HR, ppHF, and
ppLF. Hypotension usually requires further interventions such as, in the presented case,
phenylephrine administration and assisted ventilation. These are mainly reflected in the
respiratory coupling with heart rate (ppRSA). Excluding compensatory effects, a pro-
gressive long-term decrease along PROP administration in ppHF and ppLF suggests an
increasingly poor autonomic tone, possibly associated with the significant baroreflex
depression by PROP reported previously in Chen et al. [73]. The high hypnotic effect
Figure 1 EEG-based tracking of propofol and dexmedetomidine administration. Representative individual
spectrogram from a frontal EEG channel to illustrate similarities and differences during dexmedetomidine
sedation and propofol-induced general anesthesia. The spectrogram displays the frequency content of
signals as they change over time. Frequency is plotted on the y-axis, time is plotted on the x-axis, and
the amount of energy or power in the signal is indicated in color. Both spectrograms show power content in
the 0.1 to 40 Hz range. (A) Spectrogram of a volunteer research subject who received dexmedetomidine for
sedation. Dexmedetomidine sedation is marked by the onset of power centered on the 14 Hz frequency band.
(B) Spectrogram of a volunteer research subject who received a graded dosing scheme of propofol (sedation
through to general anesthesia). Propofol GA is marked by the onset of broad and power (10 to 20 Hz) that is
eventually centered on the 10 Hz frequency band.
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in the nonlinear IDLE index.
As a comparative example, the high bradycardic effect of DMED is clearly reflected
in the RR and HR instantaneous assessment. ppHF increases as soon as DMED is ad-
ministered and oscillates at significantly higher values, confirming the low sympathetic
and predominant vagal activation effect. A sustained ppLF further confirms that barore-
flex activation is maintained under administration [10]. On final note, respiratory fre-
quency decreases and becomes more regular all along DMED administration. We
further provide more details separately for each drug in the next paragraphs.The importance of using multimodal approaches, including respiration
Figure 3 shows two examples focusing on the transition during DMED administration.
These examples confirm that the mean RR and mean HR (Figure 3A,B) generally reflect a
higher bradycardic effect during DMED administration, confirmed by the increase of the in-
stantaneous vagally mediated HF HRV power (Figure 3C) and RSA gain (Figure 3F). Our
results show that, generally, ppHF increases as soon as the drug is given (see example in
Figure 3C), confirming the predominantly vagal activation effect. Such effect is not always
observed, as shown in the second example (Figure 3G,H,I,J,K,L). In this case, the absence of
the ppHF increase is clearly due to a progressive waning in respiratory variability (Figure 3L).
Figure 2 ECG-based tracking of propofol and dexmedetomidine administration. Examples of point
process (pp) characterization during propofol (PROP, left panel) and dexmedetomidine (DMED, right panel)
administration. The arrows associated to the name of the drug indicate the beginning of the infusion, whereas
the end arrows indicate drug decrease/cessation.
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demonstrated by the increase in vagal activation in all subjects (including our exam-
ples in Figure 3F and 3L). Finally, it is important to note that respiration becomes
more regular as drug administration progresses. This is validated by the lower vari-
ability of the respiratory rate around its mean value (see examples in Figure 3E,K).Towards instantaneous signatures of ANS dynamics during sedation
In this section, we present a more detailed individual dynamics as function of the drug
administration level, focusing on the linear and nonlinear HRV point process indices
separately for each drug.
Although our aims are focused on the dynamics, we accompany the dynamical study
with a brief statistical summary based on averaging our instantaneous indices. Tables 1
and 2 report median and median absolute deviation for the main instantaneous indices
obtained from the ECG and averaged for each group and stages. The first segment is
chosen within the baseline recording stage prior to the administration for both proto-
cols (between 5 and 15 min). Five levels are considered for PROP (15 min each). Two
levels are considered for DMED: 8 min within the 10 min bolus administration (1 min
after marker), and 18 min at low-level maintained administration (100 s after marker).
To give a more multifaceted portrayal, in Figures 4 and 5, we are showing results from
Figure 3 Instantaneous effects of dexmedetomidine infusion. Results of instantaneous cardio-respiratory
indices for subject 3 (A-F) and subject 9 (G-L). The dashed line (approximately 2,700 s) marks dexmedetomidine
administration time.
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ately aligned according to the experiment markers). The single subject indices give an
idea on how single events other than drug administration changes affect the dynamics,
whereas the averaged signatures, along with their confidence intervals (median absolute
deviations), facilitate a clearer interpretation of the common changes due to change in
drug levels as well as the degree of inter-subject variability for each index.
Propofol signatures (Figure 4)
These results pertain to the part of study 1 from baseline, to level 1 (L1), up to level 5
(L5), the highest level of PROP administration, and do not consider dynamics of emer-
gence from anesthesia. In the subject portrayed on the left in Figure 4, the first three
levels (baseline, L1, and L2) clearly confirm a sharp decrease in HRV, both in the LF
and HF range, confirming the high decrease in autonomic tone, both vagal and sympa-
thetic, with PROP. The relevant increase in variability at the beginning of level 3 is con-
comitant to administration of phenylephrine (arrow in the individual mean RR plot). In
particular, the resulting vasoconstriction drives the autonomic balance towards para-
sympathetic action along the rest of the administration levels (bradycardia accompanied
by high levels of ppHF together with a relevant, slow decrease in sympathovagal bal-
ance). Note that drug-induced physiological instability is not sensed by the nonlinear
index IDLE even at the individual level, which maintains sustained levels up to mid-
Table 1 Statistical analysis with propofol administration
PROP Baseline L1 L2 L3 L4 L5
Mean RR (ms) 948.9 ± 186.1 894.9 ± 197.5 880.3 ± 170.2 941.2 ± 164.8 1,047.4 ± 166.6 1,067.5 ± 203.7
Mean HR (bpm) 63.7 ± 11.88 67.49 ± 12.82 68.49 ± 13.66 64.10 ± 10.33 58.07 ± 9.12 56.85 ± 11.02
Var RR (ms2) 1194.5± 486.44 ± 366.47 292.98 ± 195.91 1,100.2 ± 851.37 492.06 ± 316.92 1,397.6 ± 1182.6
Var HR (bpm2) 2.50 ± 1.22 2.49 ± 0.63 1.46 ± 0.97 4.67 ± 4.07 2.57 ± 1.87 3.02 ± 1.58
ppLF (ms2) 1,080.7 ± 900.81 499.31 ± 309.57 262.70 ± 119.02 1,202.9 ± 1065.8 934.04 ± 478.23 1,170.4 ± 978.74
ppLFn 0.5834 ± 0.0492 0.5338 ± 0.1334 0.6508 ± 0.1663 0.7301 ± 0.0510 0.5635 ± 0.2059 0.4225 ± 0.1452
ppHF (ms2) 941.83 ± 273.91 533.83 ± 445.82 237.49 ± 163.70 642.57 ± 500.73 299.24 ± 97.62 1,204.4 ± 1056.7
ppHFn 0.4166 ± 0.0492 0.4662 ± 0.1334 0.3492 ± 0.1663 0.2699 ± 0.0510 0.4365 ± 0.2059 0.5775 ± 0.1452
LF/HF 1.9064 ± 0.6756 1.0035 ± 0.4972 2.1198 ± 1.2618 2.8623 ± 1.6639 2.0781 ± 1.5195 0.9315 ± 0.4612
IDLE 0.0085 ± 0.0469 0.0058 ± 0.0607 0.0391 ± 0.0761 0.1033 ± 0.0342 0.1262 ± 0.0300 0.1002 ± 0.0801
Median ±median absolute deviation of the main cardiovascular instantaneous point process autonomic indices. Six subjects, PROP study 1.
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Table 2 Statistical analysis with dexmedetomidine administration
DMED Baseline Bolus Maintenance
Mean RR (ms) 985.8 ± 66.7 1,067.3 ± 101.4 1,049.4 ± 66.0
Mean HR (bpm) 61.48 ± 4.09 56.49 ± 4.96 57.51 ± 3.55
Var RR (ms2) 899.78 ± 284.96 1,035.7 ± 445.75 467.09 ± 193.95
Var HR (bpm2) 4.4436 ± 0.6607 3.3026 ± 0.5365 1.27 ± 0.029
ppLF (ms2) 1,480.9 ± 517.31 1,573.2 ± 465.20 638.66 ± 313.80
ppLFn 0.5972 ± 0.0918 0.4340 ± 0.2498 0.5328 ± 0.1038i
ppHF (ms2) 849.45 ± 223.67 10.30.1 ± 409.63 503.11 ± 273.61
ppHFn 0.4028 ± 0.0918 0.5660 ± 0.2498 0.4672 ± 0.1038
LF/HF 1.7550 ± 0.8124 0.9188 ± 0.5079 1.7286 ± 0.5964
IDLE 0.0409 ± 0.0214 0.1064 ± 0.0825 0.0242 ± 0.0482
Median ±median absolute deviation of the main instantaneous point process cardiovascular indices. Six subjects, DMED
study 2.
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loss of consciousness (arrow in the individual IDLE plot). The respective averaged sig-
natures among all six subjects (Figure 4, right column) evidence the overall trends asso-
ciated with the drug levels (appropriately aligned for each subject), thus ‘blurring’ the
instantaneous effects of phenylephrine, which happens intermittently and at different
times for each subjects. Of note, the measures with highest inter-individual variability,
mirrored by a wider median absolute deviation region (in gray) are the mean RR and
HR, followed by their respective variances. Conversely, the measures with least inter-
subject variability are the two normalized LF and HF powers and, most of all, the IDLE
index of complexity. The IDLE is also showing the most coherent (increasing) trends
associated with the level of drug when looking at the average and, at the same time, sig-
nificant increases at the moment of loss of consciousness when looking at each subject
individually.
Dexmedetomidine signatures (Figure 5)
These results pertain to the part of study 2 including baseline, 10 min of loading dose
and 18 min of the following maintenance epoch. The marked bradycardic effect of the
bolus dose is clear both at the individual and group level (increasing mean RR, decreas-
ing mean HR). Bradycardia levels stabilize during maintenance. As the system is clearly
migrating to a different state during loading, HRV (Var RR, Var HR, and ppLF) in-
creases relevantly in the initial minutes and then tends to reach minimum levels by the
end of the loading dose. On the other hand, ppHF increases at the start of administra-
tion and stays elevated for the entire 10 min of loading. As a consequence, the sympa-
thovagal balance steadily decreases to minimum levels up to the end of the loading
phase. The switch in balance during the maintenance period, along with HRV
remaining at low levels, is quite probably due to the respiratory waning effect (not re-
portable for all subjects, see previous section for exemplary cases). Of note, the individ-
ual is losing consciousness at minute 8 of the loading epoch, regaining intermittent
responsiveness from minute 11 after loading starts, whereas the average range of loss
of consciousness for the group goes between 7 to 12 min after loading starts. Import-
antly, sharp increases in IDLE values can be observed around the range of loss of con-
sciousness both for the individual and the group dynamics.
Figure 4 Individual and group effects of propofol on autonomic dynamics. Instantaneous autonomic
indices extracted from the ECG for one subject (left) and averaged for six subjects (right) at baseline and
during five levels of PROP administration. Confidence regions in gray are limited by median absolute deviations.
The arrow at the end of L2 (mean RR plot) marks beginning of intermittent Phenylephrine administration. The
arrow at the beginning of L4 (IDLE plot) marks beginning of loss of consciousness.
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Our ongoing efforts are aimed at paving the way for a novel moment-to-moment ANS
assessment in different states of sedation. Our main hypothesis is that different levels
of sedation and analgesia affect the underlying neural processes and are reflected in dif-
ferent objective physiological signatures. As such, neural pathways are also differently
affected, and specific physiological signatures of sedation could potentially be disen-
tangled through appropriate experimental protocols and accurate noninvasive physio-
logical assessments.
Figure 5 Individual effects of dexmedetomidine on autonomic dynamics. Instantaneous autonomic
indices extracted from the ECG for one subject (left) and averaged for six subjects (right) at baseline and
during administration of DMED (10 min loading followed by 15 min maintenance). Confidence regions in
gray are limited by median absolute deviations.
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ment, we have devised a point process framework able to successfully characterize the
variations in heartbeat dynamics when applied to PROP and DMED administration proto-
cols. Previous results from our groups and other authors have stressed the importance of
dynamic autonomic monitoring during anesthesia, and particularly during PROP and
DMED [13,15,19,20,34,44,46-48,51,53,54,72,73,75]. In this presentation, we provide fur-
ther evidence that our refined methods for analyzing the heartbeat dynamics during ad-
ministration of specific anesthetic drugs are able to overcome nonstationary limitations,
thus providing new real-time monitoring approaches to patients receiving anesthesia.
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of heartbeat dynamics as measures defined in the time and frequency domain as well
as the instantaneous dominant Lyapunov exponent [75,83-85]. As a result, our frame-
work is able to examine the complex evolution of the unevenly sampled heartbeat dy-
namics series during anesthesia and sedation, in continuous time without the use of
interpolation filters. Remarkably, most other nonlinearity and complexity indices are
derived from non-parametric models, whereas our model is purely parametric and the
analytically derived indices can be evaluated in a dynamic and instantaneous fashion.
The proposed framework also allows for the inclusion of covariates as the respiration
activity, thus being able to estimate other meaningful measures as the instantaneous
RSA. We believe these strengths enable our method as a useful anesthesia and sedation
assessment tool taking into account also the nonlinear dynamics of heartbeat intervals
in a highly non-stationary environment. Moreover, goodness of fit measures such as
Kolmogorov-Smirnov (KS) distance and autocorrelation plots quantitatively allow to
verify the model fit as well as to choose the proper model order, which represents an-
other open issue of current parametric approaches.
In the results from the first experimental study, we show that PROP signatures are
initially (first two administration levels) characterized by a marked decrease in HRV,
both in LF and HF, confirming previous findings, and pointing at a general loss of auto-
nomic tone (both sympathetic and vagal) possibly connected with simultaneous barore-
flex deactivation/resetting. The observed delayed compensatory variations of HRV can
be attributed to sympathetic activation due to vasodilatory effect, as well as vagal acti-
vation due to intermittent phenylephrine administration. Vagal predominance is ob-
served during loss of consciousness. Our comparison between individual signatures
and signatures obtained from all subjects demonstrates that overall trends, devoid of
fast transient effect present on individual dynamics, can be observed particularly in
normalized measures. Most importantly, increased IDLE complex dynamics elicited by
increasing drug administration levels are highly correlated with the hypnotic effect (as
measured by auditory test and confirmed by EEG metrics) for the individual and with
the level of administration for the group signature. In the results from the second ex-
perimental study, we show that DMED signatures are characterized by a marked sym-
pathetic deactivation and by sustained vagal activation, clearly visible in HRV dynamics
during the first loading stage, so less during maintenance levels, where respiration wan-
ing effects are more predominant. Importantly, the IDLE complex dynamic increases in
accordance with the incidence of loss of consciousness (predominantly during the ini-
tial bolus administration). The reduced hypnotic effect compared with PROP (also
demonstrated by EEG signatures) is also confirmed by relatively low IDLE levels during
maintenance. Although we do not provide p values from statistical inference tests (be-
cause of the reduced number of subjects involved in the study), we show consistent
trends in all the linear and nonlinear heartbeat features (see Figures 4 and 5) and, thus,
provide important insights to the different cardiovascular dynamics during anesthesia
and sedation as shown in an instantaneous fashion.
The main challenge of the proposed study, and all HRV studies in general, is the high
inter-individual variability, mainly due to the complexity of the cardiovascular control
responses to intrinsic or induced perturbations of the system, particularly with drug ad-
ministration. Such variability has been the prominent limitation preventing previous
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ited population, and to provide a personalized tracking of sedation. Moreover, another
limitation of our methodology can be related to the need of a preliminary calibration
phase before it can be effectively used to estimate the instantaneous measures. Like
other parametric methods, in fact, a tuning of model parameters such as model order
and time-window W size for the local-likelihood parameter estimation. To this extent,
in the presented application, we were able to obtain reproducible and reliable results by
using standard values such a W = 90 s, as well as optimal model orders by minimizing
the KS statistics.
Given these limitations, we will center our future studies on two principles: (a) the
high variability reflected in the resulting statistical predictions, and physiological inter-
pretations must be accompanied by a multiorgan approach and a careful choice of
complementary information; and (b) a powerful and reliable classification algorithm is
required to use dimensionality towards optimal discrimination. We believe that valid-
ation of accurate and reliable scales based on the instantaneous identification, together
with the careful choices in sedation levels (which are the results of our extensive pre-
liminary investigations) will provide a more sensitive assessment and interpretation of
the results. In particular, differently than previous investigations, we will consider EEG
and HRV measures together and feed them to a classifier to find the most efficient
combination signature. Most importantly, we will be able to consider a novel measure
of RSA, which accounts for respiratory pattern variations in assessing sympathovagal
dynamics. Our future studies will determine by which degree a combined index of the
ANS measures is able to accurately quantify sedation in controlled scenarios, also esti-
mating recently proposed instantaneous nonlinear measures based on high-order spec-
tral analysis and entropy [70,83-90]. We will devise classifiers which might provide
enough power to produce a combination of measures of autonomic outflow validating
the assessment for each single subject, thus paving the way for the feasibility for a real-
time monitoring tool able to track sedation in uncontrolled scenarios.
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